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ABSTRACT
Objectives: The aim of the study was to assess the utility of mid-trimester ultrasound parameters in predicting birth weight 
in low-risk pregnancy and high-risk pregnancy complicated with pregestational diabetes mellitus.
Material and methods: A study group comprised 97 healthy women and 160 women with pregestational diabetes (PGDM, 
type 1), all in singleton pregnancy. Ultrasound examination was performed between weeks 11 and 14, and in weeks 20 and 
30 of gestation, based on recommendations of the Polish Society of Gynecologists and Obstetricians, Ultrasonography 
Division. We also checked uterine artery blood flow parameters.
Results: There is a correlation between the birth weight and ultrasound-ascertained parameters, including those characteris-
ing uterine artery blood flow and foetal biometry [abdominal circumference (AC), femoral length (FL), biparietal dimension 
(BPD)].The biparietal dimension (BPD), head circumference (HC) abdominal circumference (AC) and pre-existing diabetes 
are the ultrasound predictors of LGA. The presence of an early-diastolic uterine artery blood flow waveform notching, as 
well as the uterine artery pulsatility index (UAPI), femoral length (FL) and hypertension in pregnancy are the ultrasound 
predictors of SGA. In the subset of women with pre-gestational diabetes (PGDM), there is a negative correlation between 
the birth weight and the uterine artery pulsatility index and early-diastolic uterine artery blood flow waveform notching. 
In women with pre-gestational diabetes mellitus (PGDM), femoral length (FL) is a significant predictor of LGA and in case of 
SGA significant predictors are uterine artery pulsatility index, artery blood flow waveform notching and femoral length (FL).
Conclusions: Midtrimester ultrasound parameters with confirmed usefulness in the prediction of birth weight in low-risk 
pregnancy and high-risk pregnancy complicated with pregestational diabetes mellitus include: uterine artery PI, early-di-
astolic uterine artery blood flow waveform notching and foetal biometry.
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INTRODUCTION
The birth weight between the 10th and 90th percentile is 
crucial to ensure proper course of labour. It also reduces the 
risk of both early and late developmental complications. The 
excessive foetal weight is referred to as macrosomia and 
large for gestational age (LGA). The term macrosomia is 
related with a birth weight over 4000 g or 4500 g, regardless 
of gestational age, with appropriate body proportions [1], 
whereas LGA denotes a situation where the birth weight 
exceeds the 90th percentile for the relevant gestational age 
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[1]. Foetal hypotrophy includes cases of small for gestational 
age (SGA) and intrauterine growth restriction (IUGR). The 
term “small for gestational age” has been coined to denote 
foetuses unable to reach normal body weight (defined as the 
10th percentile in a growth chart),whereas the IUGR indicates 
foetal growth below the genetically expected potential and 
applies to foetuses not reaching their potential optimum 
growth and weight, with growth dynamics not correspond-
ing to the gestational age [2].
Foetal hypertrophy is associated with a number of pre-
natal, perinatal and postnatal complications. During the 
perinatal period, LGA is associated with a higher incidence 
of cephalopelvic disproportion, maternal pelvic floor and 
rectal sphincter muscle injury, shoulder dystocia and, in 
turn, brachial plexus palsy, hypoxia and neonatal death [3]. 
Long-term observation of children with macrosomia shows 
increased rates of overweight, obesity, diabetes, and hyper-
tension in adult life. Children with birth weight over 4000 g 
have been found to have increased incidence of insulin 
resistance, risk of metabolic syndrome, abnormal fasting 
glycaemia and impaired glucose tolerance in childhood [4].
Foetal hypotrophy, on the other hand, is associated with 
an increased incidence of intrauterine death, prematurity 
and cerebral palsy [3].
In 1980’s, the first studies evaluated the utility of uterine 
artery blood flow parameters in gestational trophoblas-
tic disease and increased uterine artery resistance. Stuart 
Campbell published his first paper assessing blood flow 
in uteroplacental circulation in IUGR [5]. Fleischer et al. 
[6] described changes to the uterine artery blood flow 
waveform and an increase in the systolic-to-diastolic time 
index (SDI) in pregnant women with elevated blood pres-
sure. In their paper on first trimester screening for gesta-
tional hypertension and pre-eclampsia, Gomez et al. [7] 
showed significantly elevated pulsatility index (PI) values 
in uterine arterial blood flow in patients who developed 
pre-eclampsia after 20 gestational weeks compared to 
the controls. A number of other studies followed, leading 
to the development of universal screening for gestational 
hypertension, pre-eclampsia and IUGR, i.e. all conditions as-
sociated with abnormal foetal growth leading to abnormal 
birth weight. This enabled us to attempt to investigate the 
relationship between mid-trimester uterine PI values and 
subsequent birth weight.
The aim of the study was to assess the utility of mid-tri-
mester ultrasound parameters in predicting birth weight in 
low-risk pregnancy and high-risk pregnancy complicated 
with pregestational diabetes mellitus.
MATERIAL AND METHODS
The study sample was described in detail in our previous 
paper (Maternal factors and placental function parameters 
in early pregnancy as predictors of birth weight in low risk 
populations and among patients with pre-gestational dia-
betes) [8].
The women presenting for a routine antenatal appoint-
ment at 20 gestational weeks had their blood pressure 
measured three times using a standardized (as per FMF 
recommendations) manometer. 
During the same appointment, an ultrasound assess-
ment was carried out using the 3.5 MHz abdominal probe 
in order to assess foetal biometry and anatomy as per the 
guidelines of the Ultrasound Section of Polish Society of 
Gynaecologists and Obstetricians as well as bilateral uter-
ine artery blood flow as they branch out of the respective 
internal iliac arteries. The pulsatility index (PI) was the key 
assessed blood flow parameter. Each measurement was 
taken three times, with the highest, lowest and mean values 
included in statistical calculations. Furthermore, the uterine 
artery blood flow waveform was assessed for the presence 
of early-diastolic notching [9].
The statistical analysis included a logistic regression 
and a multiple regression models carried out using the 
SPSS package. 
RESULTS
Study group characteristics are shown in Table 1.
There were no significant differences between healthy 
pregnant women and those with pregestational diabetes 
in terms of: height, weight, BMI, hypertension, right and 
left uterine artery pulsatility index and mean pulsatility 
index determined at about 20 gestational weeks, presence 
of the early diastolic right or left uterine artery blood flow 
waveform notching, birth weight and incidence of SGA. 
The mean age of women with pregestational diabetes 
was 29.8 years as compared to the mean age of 28.5 years 
in healthy pregnant women. Both systolic and diastolic 
blood pressure values at 20 gestational weeks were sig-
nificantly higher in patients with pregestational diabetes 
mellitus than in healthy pregnant women (110.1 mmHg 
vs 107.5 mmHg, p = 0.25 and 68.7 mmHg vs 65.5 mmHg, 
p = 0.23 for systolic and diastolic BP, respectively). The 
mean arterial blood pressure assessed at 20 gestational 
weeks was significantly lower in PGDM patients than in 
patients in non-PGDM women (82.5 vs 86.5, p = 0.030).The 
incidence of LGA in PGDM patients was significantly higher 
than in non-DM patients (21.6% vs 9%, p = 0.017).
Statistical analysis demonstrated that the significant 
birth weight predictors were presence of the early diastolic 
right or left uterine artery blood flow waveform notching 
and the mean uterine artery pulsatility index with the in-
verse association between them. There was a positive cor-
relation between the metabolic parameter, i.e. abdominal 
circumference (AC), and the bone growth parameter, i.e. 
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femoral length (FL), and the birth weight. After adjustment 
for pregestational weight, PAPPA level and hypertension 
in early pregnancy, these parameters remained significant 
predictors of birth weight (Tab. 2).
The logistic regression demonstrated that the bipari-
etal dimension [(BPD), p = 0.049], head circumference [(HC), 
p = 0.044], abdominal circumference [(AC), p = 0.013] and 
pre-existent diabetes (p = 0.020) were significant predictors 
of LGA in the entire study sample. Pre-existent diabetes in-
creased the risk of LGA three-fold compared to non-PGDM 
women. Positive correlation has been demonstrated between 
the biometric parameters, i.e. BPD, HC, AC and LGA incidence 
(Tab. 3). However, when the logistic regression model was ad-
justed for the crown-rump length (CRL), nuchal translucency 
(NT), P1GF level and mean pulsatility index in uterine arteries 
assessed during the routine appointment at 12 gestational 
weeks, all parameters listed in Table 3 proved non-significant.
The significant predictors of SGA in the entire study sam-
ple were the presence of an early-diastolic left uterine artery 
blood flow waveform notching (p = 0.018), mean uterine 
artery pulsatility index (p = 0.010), femoral length (p = 0.016) 
and gestational hypertension (p = 0.037). The highest risk of 
SGA was associated with a high mean uterine artery pulsatil-
ity index [(UAPI), OR = 9.97]. In the logistic regression model 
presented in Table 4, the presence of an early-diastolic left 
uterine artery blood flow waveform notching increased the 
risk of SGA five-fold, while hypertensive disease of preg-
nancy increased that risk three-fold.
In the subset of women with pregestational diabetes 
(PGDM), the analysis demonstrated a negative correlation 
between the birth weight and the following: right uterine 
artery pulsatility index (p = 0.010), an early-diastolic right 
uterine artery blood flow waveform notching (p = 0.007), 
an early-diastolic left uterine artery blood flow waveform 
notching (p = 0.010), higher (p = 0.008) and mean (p = 0.028) 
uterine artery pulsatility indices. After adjustment for ma-
ternal height, PAPPA and beta-HCG levels, these parameters 
still remained significant birth weight predictors (Tab. 5).
In women with pre-gestational diabetes mellitus 
(PGDM), femoral length (FL) was a significant predictor of 
Table 1. Study group characteristics
Parameter Non-DM PGDM p
Age 28.5 ± 5.3 29.8 ± 4.7 0.030
Height 162.2 ± 6.0 166.0 ± 6.3 0.569
Pregestational weight 66.2 ± 12.4 65.3 ± 14.6 0.227
Pregestational BMI 24.3 ± 4.7 23.7 ± 5.1 0.161
Maternal hypertensive 
disorders [%] 7.2% 11.3% 0.386
Microvascular complications 
present (only patients with 
PGDM)
– 16.3%
Age on DM diagnosis (only 
patients with PGDM) – 18.1 ± 8.5
Diabetes duration (only 
patients with PGDM) – 17.0 ± 8.5
HbA1c at 20 gestational weeks 
(only patients with PGDM) – 5.6 ± 0.95
Systolic BP at 20 gestational 
weeks 107.5 ± 12.5 110.1 ± 11.7 0.025
Diastolic BP at 20 gestational 
weeks 65.5 ± 8.8 68.7 ± 10.5 0.023
Mean BP at 20 gestational 
weeks 86.5 ± 9.7 82.5 ± 10.2 0.008
RUA PI at 20 gestational 
weeks 0.86 ± 0.31 0.89 ± 0.29 0.212
LUA PI at 20 gestational 
weeks 0.93 ± 0.29 0.95 ± 0.38 0.553
Right or left UA waveform 
notching [%] 17.2 10.8 0.274
Mean UAPI 0.89 ± 0.29 0.92 ± 0.28 0.246
Birth weight 3314 ± 512 3388 ± 596 0.191
LGA % 9.0% 21.6% 0.017
SGA % 9.0% 11.5% 0.654
BMI — body mass index; PGDM — pre-gestational diabetes; UAPI — uterine 
artery pulsatility index; LGA — large for gestational age; SGA — small for 
gestational age
Table 2. Independent mid-trimester birth weight (a dependent variable) predictors in the entire cohort
Parameter Standardised coefficient B Non-standardised coefficient B 95% CI for B Adjusted R2 p
Right or left UA 
waveform notching
Unadjusted –0.215 –313.44 –540.38; –86.50 0.04 0.007
Ad –0.232 –377.8 –622.4; –133.3 0.11 0.003
Mean PI in uterine 
arteries
Unadjusted –0.195 –362.70 –652.6; –72.84 0.03 0.015
Ad –0.212 –408.7 –715.1; –102.3 0.098 0.009
Abdominal 
circumference (AC)
Unadjusted 0.158 4.51 0.62; 8.41 0.02 0.023
Ad 0.164 4.45 0.88; 8.01 0.09 0.015
Femoral length (FL) Unadjusted 0.165 19.6 3.42; 35.70 0.02 0.018
Ad 0.157 18.7 2.9; 34.6 0.087 0.021
Ad — adjusted for pregestational weight, PAPPA and hypertensive disorders of pregnancy
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LGA (p = 0.052). After adjustment for early pregnancy (12 ges-
tational weeks) PAPPA level and mean uterine artery pulsa-
tility index, it still remained a significant predictor of LGA 
(p = 0.032). Albeit significant, the odds ratio of LGA in foetuses 
with higher FL was only slightly above 1. The adjustment for 
early pregnancy (12 gestational weeks) for PAPPA level and 
mean uterine artery pulsatility index did not affect the odds 
ratio of LGA in foetuses with higher FL (OR 1.15, Tab. 6).
In women with pre-gestational diabetes, the following 
were significant predictors of SGA: right uterine artery pulsa-
tility index (p = 0.005), an early-diastolic right and left uterine 
artery blood flow waveform notching (p = 0.008), higher 
of the two uterine artery pulsatility indices (p = 0.005), 
mean uterine artery pulsatility index (p = 0.008) and femo-
ral length (p = 0.039). Regression model adjustment for 
P1GF level at 12 gestational weeks did not affect the sig-
nificance of most analysed predictors, with FL being the 
only exception.
The highest risk of SGA was demonstrated in foetuses 
with mean uterine artery pulsatility index (unadjusted 
Table 4. Independent predictors of SGA in the entire study sample — logistic regression analysis with SGA presence/absence as a dependent 
variable. The data are presented as an unadjusted odds ratio
Independent variable in the logistic regression ENTER model Regression coefficient B OR 95% CI for OR p
Left UA waveform notching 1.602 4.96 1.31; 18.74 0.018
Mean UAPI 2.3 9.97 1.75; 56.79 0.010
FL –0.132 0.88 0.79; 0.97 0.016
Hypertensive disorders of pregnancy YES 1.19 3.3 1.08; 10.02 0.037
UAPI — uterine artery pulsatility index; FL — femoral length 
Table 5. Independent mid-trimester birth weight (a dependent variable) predictors in PGDM subset. The calculations were adjusted for early 
pregnancy factors identified as birth weight predictors in PGDM subset
Parameter Standardised coefficient B Non-standardised coefficient B 95% CI for B Adjusted R2 p
PI in the right UA
Unadjusted –0.285 –520.46 –912.8; –128.2 0.07 0.010
Ad –0.263 –537.13 –952.7; –121.6 0.18 0.012
Right UA waveform 
notching
Unadjusted –0.296 –605.5 –1043.6; –167.4 0.09 0.007
Ad –0.307 –702.5 –1155.9; –249.0 0.21 0.003
Left UA waveform 
notching
Unadjusted –0.285 –544.58 –954.3; –134.9 0.07 0.010
Ad –0.318 –677.2 –1104.8; –249.6 0.21 0.002
A higher of the two 
UAPI values
Unadjusted –0.291 –429.8 –746.3; –113.3 0.07 0.008
Ad –0.259 –409.1 –746.9; –71.3 0.17 0.018
Mean UAPI
Unadjusted –0.244 –479.3 –906.4; –52.3 0.05 0.028
Ad –0.217 –466.8 –928.4; –5.2 0.20 0.048
Ad — adjusted for maternal body height, PAPPA and beta-HCG; UAPI — uterine artery pulsatility index
Table 3. Independent mid-trimester predictors of LGA in the entire sample - logistic regression analysis with LGA presence/ absence as a dependent 
variable. The data are presented as both unadjusted odds ratio and odds ratio adjusted for early pregnancy assessed factors
Independent variable in the logistic regression ENTER model Regression coefficient B OR 95% CI for OR p
BPD
Unadjusted 0.067 1.07 1.00; 1.14 0.049
Ad 0.002 1.002 0.92; 1.09 0.956
HC
Unadjusted 0.015 1.015 1.00; 1.03 0.044
Ad 0.005 1.005 0.99; 1.02 0.617
AC
Unadjusted 0.025 1.025 1.005; 1.045 0.013
Ad 0.006 1.006 0.98; 1.03 0.607
Pre-existent diabetes YES
Unadjusted 1.03 2.8 1.2; 6.7 0.020
Ad 0.375 1.46 0.54; 3.9 0.461
Ad — adjusted for CRL, NT, PlGF and mean UAPI at 12 gestational weeks; BPD — biparietal dimension; HC — head circumference; AC — abdominal circumference
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OR = 78.3 and adjusted OR = 141.7). The risk of SGA in 
foetuses with higher right uterine artery pulsatility index 
was 60-fold higher than in those with lower UAPI (unad-
justed OR = 60.4 and adjusted OR = 63.2). This may indicate 
a lateral circulatory shift in pregnancy with higher vascular 
resistance in the right uterine artery than in the left one. The 
risk of SGA in foetuses with higher uterine artery pulsatility 
index was 23-fold and 43-fold higher in the unadjusted and 
adjusted model, respectively, than in those with lower UAPI. 
The presence of an early-diastolic right and left uterine 
artery blood flow waveform notching increased the risk 
of SGA 12-fold in the unadjusted model and 17-fold in the 
adjusted model. The femoral length (FL) did not increase 
the risk of SGA in both unadjusted and adjusted model 
but served as a significant SGA predictor in the unadjusted 
model (Tab. 7).
DISCUSSION
The analysis of the mid-trimester material in this study 
demonstrated a number of associations between ultrasound 
parameters and birth weight. It confirmed the previously 
observed correlations between the foetal biometric param-
eters, i.e. BPD, HC, AC, FL and birth weight, as well as the 
effect of first-trimester placental markers and mean uterine 
artery pulsatility index which we have reported previously. It 
showed that the uterine artery pulsatility index assessed in 
both first and second trimester is not only a prognostic pa-
rameter of pre-eclampsia and IUGR but also of birth weight.
Our study, although carried out in a small sample, con-
firmed the significance of abdominal circumference (AC) 
and femoral length (FL) in birth weight estimation. This 
finding is corroborated by the study based on ultrasound 
foetal biometry analysis between 22 and 43 gestational 
weeks in 5163 pregnancies, which proved that the Hadlock 
formula developed in 1985, based on the measurements of 
head circumference (HC), abdominal circumference (AC) and 
femoral length (FL) provides the most accurate birth weight 
estimation and can be used in all foetuses, included those 
with suspected intrauterine growth abnormalities [10].
The paper reporting a mid-trimester screening for LGA 
based on maternal history and foetal biometry was pub-
lished in Ultrasound in Obstetrics and Gynecology [11]. That 
British study was carried out in samples of 76300, 54999, 
25727 and 6181 pregnant women. The procedure included 
antenatal ultrasound scans at 11–13, 19–24, 30–34, and 
35–37 gestational weeks LGA was defined as foetal weight 
above the 95th percentile. The likelihood of LGA increased 
with increasing maternal weight and height as well as in 
women with pre‐existing diabetes mellitus Type I, but de-
creased in those with chronic hypertension, cigarette smok-
ers and in nulliparous women. The mid-trimester screening, 
based on maternal history and foetal biometry, had detec-
Table 6. Independent predictors of LGA in women with pre-gestational diabetes. Logistic regression analysis with LGA present/absent as 
a dependent variable. The data are presented as odds ratios - unadjusted and adjusted for known first-trimester risk factors for LGA
Independent variable in the logistic regression ENTER model Regression coefficient B OR 95% CI for OR p
FL
Unadjusted 0.115 1.12 0.999; 1.26 0.052
Ad 1.15 1.013; 1.32 0.032
Ad — adjusted for PAPPA and mean UAPI at 12 gestational weeks; FL — femoral length
Table 7. Independent predictors of SGA in women with pre-gestational diabetes. Logistic regression analysis with SGA present/absent as 
a dependent variable. The data are presented as odds ratios — unadjusted and adjusted for known first-trimester risk factors for SGA
Independent variable in the logistic regression ENTER model Regression coefficient B OR 95% CI for OR p
RUA PI
Unadjusted 4.101 60.4 3.4; 1086.4 0.005
Ad 4.147 63.2 2.7; 1457.6 0.010
Right or left UA waveform notching
Unadjusted 2.44 11.5 1.9; 69.9 0.008
Ad 2.83 16.9 2.3; 124.8 0.005
A higher of the two UAPI values
Unadjusted 3.17 23.7 2.6; 212.1 0.005
Ad 3.77 43.2 2.6; 714.2 0.008
Mean UAPI
Unadjusted 4.36 78.3 3.1; 1998.6 0.008
Ad 4.95 141.7 2.8; 723.9 0.014
FL
Unadjusted -0.138 0.87 0.76; 0.99 0.039
Ad -0.111 0.89 0.78; 1.03 0.123
Ad — adjusted for PlGF at 12 gestational weeks; UAPI — uterine artery pulsatility index; FL — femoral length
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tion rates of 37%, 51% and 68%, respectively, with false 
positive rates of 5%, 10% and 20%, respectively.
Poon et al. evaluated the utility of complex screening 
based on maternal history, foetal biometry as well as bio-
physical and biochemical markers ascertained at 19–24 ges-
tational weeks, in predicting SGA, excluding pre-eclampsia, 
and selecting the optimum timeframe for the third trimes-
ter ultrasound scan (at either 32 or 36 gestational weeks).
The screening, based on maternal history, foetal biometry, 
uterine artery PI, P1GF and AFP levels, was carried out in 
7816 pregnant women, including 389 cases of SGA. Not 
only was the screening crucial for SGA prediction, but it also 
determined the optimum timeframe for the third trimes-
ter ultrasound scan (at either 32 or 36 gestational weeks).
The SGA detection rates (DR) were 100%, 78% and 42% for 
foetuses born before 32, between 32–36 and after 37 gesta-
tional weeks, respectively, with a false positive rate of 10%.
The third-trimester scan was needed at 32 gestational weeks 
in 11% and at 36 gestational weeks in 44% of the screened 
women, but not needed at any time in the third trimester 
in 57% of the screened women [12].
Lesmes et al. reported a similar mid-trimester screening 
protocol, yet not including biomarker levels. The screening 
algorithm for SGA prediction (referred to as foetal weight 
below the 5th percentile) carried out at 19–24 gestational 
weeks was based on maternal history, MAP, foetal biometry 
and uterine artery pulsatility index (PI). Its utility in selecting 
the optimum timeframe for the third trimester ultrasound 
scan (at either 32 or 36 gestational weeks) was also assessed. 
In a group of 63,975 screened women, SGA was confirmed in 
3702 (5.8%) cases. The detection rates (DR) of their screen-
ing based on maternal history, foetal biometry and uterine 
artery pulsatility index were 90%, 68% and 44% for foetuses 
born before 32, between 32–36 and after 37 gestational 
weeks, respectively, with a false positive rate of 10%.The 
mean arterial pressure (MAP) inclusion in the algorithm did 
not improve the results. Based on a hypothetical model with 
an assumed SGA detection rate of 80%, they estimated that 
the third-trimester scan was needed at 32 gestational weeks 
in 17% and at 36 gestational weeks in 38% of the screened 
women, but not needed at any time in the third trimester 
in 62% of the screened women [13].
Familiari et al. reported a significant predictive role of 
uterine artery blood flow parameters in SGA screening. Their 
second trimester screening administered to 23,894 pregnant 
women at 19–24 gestational weeks was based on maternal 
history including age, BMI and ethnicity; foetal biometry 
and uterine artery pulsatility index. All abovementioned 
parameters correlated significantly with the risk of SGA < 5th 
centile (p < 0.01). Uterine artery pulsatility index alone was 
capable of predicting 25%, 60% and 77% of SGA in foetuses 
born at > 37, < 37 and < 32 gestational weeks, respectively, 
with a false positive rate of 10%.Including foetal biomet-
rics, maternal history and uterine artery pulsatility index 
increased SGA detection to 40%, 66% and 89% in foetuses 
born at > 37, < 37 and < 32 gestational weeks, respectively, 
with a false positive rate of 10% [14].
Parry et al. described a similar study conducted in 
8024 pregnant women, assessed for SGA during three con-
secutive antenatal visits. They measured bilateral uterine 
artery resistance and pulsatility indices and evaluated the 
presence of an early-diastolic uterine artery blood flow 
waveform notching in an ultrasound carried out between 
16 weeks 0 days and 22 weeks 6 days gestation. SGA defined 
as birth weight below the 5th percentile was confirmed 
in 358 cases (4.5%). The positive predictive value for this 
threshold was below 15%, with the area under the curve 
(AUC) of 0.50–0.60. The AUC additionally improved to 0.63–
0.66 after including maternal age, BMI, ethnicity, smoking 
status, chronic hypertension, and pre-existing diabetes in 
the model. This test was concluded not to be clinically useful 
for predicting SGA [15].
CONCLUSIONS
1. There is a correlation between the birth weight and 
ultrasound-ascertained parameters, including those 
characterising uterine artery blood flow and foetal bi-
ometry [abdominal circumference (AC), femoral length 
(FL), biparietal dimension (BPD)].
2. The biparietal dimension (BPD), head circumference 
(HC) abdominal circumference (AC) and pre-existing 
diabetes are the ultrasound predictors of LGA.
3. The presence of an early-diastolic uterine artery blood 
flow waveform notching, as well as the uterine artery 
pulsatility index (UAPI), femoral length (FL) and hyper-
tension in pregnancy are the ultrasound predictors of 
SGA.
4. In pregnant women with pregestational diabetes 
(PGDM), there is a negative correlation between the 
birth weight and the uterine artery pulsatility index 
and early-diastolic uterine artery blood flow waveform 
notching.
5. In pregnant women with pre-gestational diabetes mel-
litus (PGDM), femoral length (FL) is apredictor of LGA 
and uterine artery pulsatility index, artery blood flow 
waveform notching and femoral length (FL) are predic-
tors in case of SGA.
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